Welcome to our lab homepage!!
To Prospective International Students
We are recruiting graduate students. On the other hand, due to limitation of lab space and ensuring instruction time, we can not accept all applicants.
If you wish to study in our lab, please contact Professor Hatakeyama by e-mail between June and early August of the year prior to the year you wish to study in my lab. We will make a decision on acceptance after an online interview.
News
2024.09.03
Presentation
2024.08.27
News
The research proposals by Assistant Professor Tamemoto and Ruiheng TANG (D2) have been accepted for cSIMVA vaccine challenge Grants 2024. Congratulations!!
2024.03.31
Presentation
2024.02.21
Paper
A paper has been accepted in Biol Pharm Bull (IF=2.0)! Congratulations!
Research
Immune checkpoint inhibitor-related projects
Immune checkpoint inhibitors are cancer immunotherapies that hold great promise in cancer treatment. However, they do not work in a large number of patients, with a response rate of only 20%. Another problem is the side effects, the mechanisms of which are unknown. We are working on research to solve these clinical problems.
脂質ナノ粒子による核酸医薬の開発
温熱耐性のメカニズムの解明と新規がん温熱・免疫複合療法へ
がんは熱に弱いとされており、がん温熱療法の研究が進められていますが標準療法には至っておらず様々な課題が存在します。我々は温熱に耐性をもつがん細胞を発見し、これが温熱療法の効果が不十分な原因の一つと考えています。現在、耐性機構の解明と、免疫療法との組み合わせによる効果的な治療法の開発に向けた研究に取り組んでいます。